Frequency Appoints Jeffery T. Lichtenhan to Clinical Development Team

Frequency Therapeutics, Inc (Nasdaq: FREQ) announced the expansion of its clinical development team with the addition of Jeffery T. Lichtenhan, PhD, an expert in hearing diagnostics and measurement.